186 related articles for article (PubMed ID: 34176265)
21. Exosomal miR-200c suppresses chemoresistance of docetaxel in tongue squamous cell carcinoma by suppressing TUBB3 and PPP2R1B.
Cui J; Wang H; Zhang X; Sun X; Zhang J; Ma J
Aging (Albany NY); 2020 Apr; 12(8):6756-6773. PubMed ID: 32310826
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-302 represses epithelial-mesenchymal transition and cisplatin resistance by regulating ATAD2 in ovarian carcinoma.
Ge T; Liu T; Guo L; Chen Z; Lou G
Exp Cell Res; 2020 Nov; 396(1):112241. PubMed ID: 32835657
[TBL] [Abstract][Full Text] [Related]
23. Quercetin suppresses drug-resistant spheres via the p38 MAPK-Hsp27 apoptotic pathway in oral cancer cells.
Chen SF; Nieh S; Jao SW; Liu CL; Wu CH; Chang YC; Yang CY; Lin YS
PLoS One; 2012; 7(11):e49275. PubMed ID: 23152886
[TBL] [Abstract][Full Text] [Related]
24. Exosomal miR-4443 promotes cisplatin resistance in non-small cell lung carcinoma by regulating FSP1 m6A modification-mediated ferroptosis.
Song Z; Jia G; Ma P; Cang S
Life Sci; 2021 Jul; 276():119399. PubMed ID: 33781830
[TBL] [Abstract][Full Text] [Related]
25. Exosomes Serve as Nanoparticles to Deliver Anti-miR-214 to Reverse Chemoresistance to Cisplatin in Gastric Cancer.
Wang X; Zhang H; Bai M; Ning T; Ge S; Deng T; Liu R; Zhang L; Ying G; Ba Y
Mol Ther; 2018 Mar; 26(3):774-783. PubMed ID: 29456019
[TBL] [Abstract][Full Text] [Related]
26. Hypoxia-induced tumor exosomes promote angiogenesis through miR-1825/TSC2/mTOR axis in oral squamous cell carcinoma.
Capik O; Gumus R; Karatas OF
Head Neck; 2023 Sep; 45(9):2259-2273. PubMed ID: 37449548
[TBL] [Abstract][Full Text] [Related]
27. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
Lu M; Wang C; Chen W; Mao C; Wang J
DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
[TBL] [Abstract][Full Text] [Related]
28. Exosome-derived microRNAs in oral squamous cell carcinomas impact disease prognosis.
Chen CM; Chu TH; Chou CC; Chien CY; Wang JS; Huang CC
Oral Oncol; 2021 Sep; 120():105402. PubMed ID: 34174519
[TBL] [Abstract][Full Text] [Related]
29. Antitumor effect of a Pt-loaded nanocomposite based on graphene quantum dots combats hypoxia-induced chemoresistance of oral squamous cell carcinoma.
Wei Z; Yin X; Cai Y; Xu W; Song C; Wang Y; Zhang J; Kang A; Wang Z; Han W
Int J Nanomedicine; 2018; 13():1505-1524. PubMed ID: 29559779
[TBL] [Abstract][Full Text] [Related]
30. Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential.
Zhao L; Ren Y; Tang H; Wang W; He Q; Sun J; Zhou X; Wang A
Oncotarget; 2015 Dec; 6(42):44538-50. PubMed ID: 26517090
[TBL] [Abstract][Full Text] [Related]
31. Up-regulation of TNF-alpha/NFkB/SIRT1 axis drives aggressiveness and cancer stem cells accumulation in chemoresistant oral squamous cell carcinoma.
de Castro LR; de Oliveira LD; Milan TM; Eskenazi APE; Bighetti-Trevisan RL; de Almeida OGG; Amorim MLM; Squarize CH; Castilho RM; de Almeida LO
J Cell Physiol; 2024 Feb; 239(2):e31164. PubMed ID: 38149816
[TBL] [Abstract][Full Text] [Related]
32. MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1.
Chen L; Zhu Q; Lu L; Liu Y
Bioengineered; 2020 Dec; 11(1):91-102. PubMed ID: 31906769
[TBL] [Abstract][Full Text] [Related]
33. Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner.
Wang B; Zhang Y; Ye M; Wu J; Ma L; Chen H
Curr Drug Metab; 2019; 20(10):804-814. PubMed ID: 31424364
[TBL] [Abstract][Full Text] [Related]
34. Alpinetin Inhibits Oral Squamous Cell Carcinoma Proliferation via miR-211-5p Upregulation and Notch Pathway Deactivation.
Guo Y; Chen Y; Liu H; Yan W
Nutr Cancer; 2020; 72(5):757-767. PubMed ID: 31403340
[No Abstract] [Full Text] [Related]
35. Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3.
Huang Z; Zhang Y; Li H; Zhou Y; Zhang Q; Chen R; Jin T; Hu K; Li S; Wang Y; Chen W; Huang Z
Cell Death Dis; 2019 Dec; 10(12):936. PubMed ID: 31819048
[TBL] [Abstract][Full Text] [Related]
36. Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells.
Zheng P; Chen L; Yuan X; Luo Q; Liu Y; Xie G; Ma Y; Shen L
J Exp Clin Cancer Res; 2017 Apr; 36(1):53. PubMed ID: 28407783
[TBL] [Abstract][Full Text] [Related]
37. SARI inhibits growth and reduces survival of oral squamous cell carcinomas (OSCC) by inducing endoplasmic reticulum stress.
Priyadarshini M; Maji S; Samal SK; Rath R; Li J; Das SK; Emdad L; Kundu CN; Fisher PB; Dash R
Life Sci; 2021 Dec; 287():120141. PubMed ID: 34774620
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of ROS/NUPR1-dependent autophagy antagonises repeated cadmium exposure -induced oral squamous cell carcinoma cell migration and invasion.
Fan T; Chen Y; He Z; Wang Q; Yang X; Ren Z; Zhang S
Toxicol Lett; 2019 Oct; 314():142-152. PubMed ID: 31319114
[TBL] [Abstract][Full Text] [Related]
39. Activation of the
Lin SC; Wu HL; Yeh LY; Yang CC; Kao SY; Chang KW
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322437
[TBL] [Abstract][Full Text] [Related]
40. Macrophage‑derived exosomes attenuate the susceptibility of oral squamous cell carcinoma cells to chemotherapeutic drugs through the AKT/GSK‑3β pathway.
Tomita R; Sasabe E; Tomomura A; Yamamoto T
Oncol Rep; 2020 Nov; 44(5):1905-1916. PubMed ID: 32901850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
